Internal Medicine - Issue 5/2015

90th birthday of prof. MD. Jiri Widimsky, MD., FESC, FAHA

376

Effect of spironolactone in patients with heart failure and preserved left ventricular function – TOPCAT study

Jiří Widimský Sr

Reviews

387

New version of classification of pulmonary hypertension

Michael Aschermann

392

Hypertension in females

Renata Cífková

401

White-coat hypertension and masked hypertension

Jan Filipovský

410

Controversies accumulated around betablockers

Jaromír Hradec

417

Is there a need to treat atrial fibrillation aggressively?

Josef Kautzner

421

The role of uric acid and allopurinol therapy in cardiovascular disease

Aleš Linhart, Daniel Rob

431

Outpatient treatment of venous thromboembolic disease

Radovan Malý, Jaroslav Malý

451

Hyperosmolar hyperglycemic state

Jaroslav Rybka, Jerguš Mistrík

458

Combination treatment of hypertension in 2015

Jindřich Špinar, Jiří Vítovec, Lenka Špinarová, Miroslava Bendová

466

The current state and future of care of patients with congenital heart defects

Miloš Táborský, Jana Popelová, Anna Nečasová, Jan Janoušek, Štěpán Černý, Petr Němec, Jan Pirk, Milan Šamánek

470

Inhibition of renin-angiotensin-aldosterone system in heart failure, or from CONSENSUS to PARADIGM-HF

Jiří Vítovec, Jindřich Špinar, Lenka Špinarová

475

Hemocoagulation – New views on the old cascade

Jan F. Vojáček

480

Primary hyperaldosteronism: problems of diagnostic approaches

Jiří Widimský Jr

484

Neuro-cardiology or cardio-neurology – a new specialization of the future?

Petr Widimský, Ivana Štětkářová

487

Pheochromocytoma – why is its early diagnosis so important for patient?

Tomáš Zelinka, Jiří Widimský Jr

Original Contributions

398

The effect of adding phytosterol to hypolipidemic therapy with statins on the size of lipoprotein particles in patients with very high cardiovascular risk

Andrej Dukát, Ján Gajdošík, Peter Sabaka, David Baláž, Lucia Mistríková, Stanislav Oravec, Peter Gavorník, Ľudovít Gašpar

406

Personalized pharmacotherapy of digoxin

Milan Grundmann, Ivana Kacířová

439

In what extend we can reach the current LDL-cholesterol treatment goals in secondary prevention

Otto Mayer Jr, Jan Bruthans V Zastoupení Řešitelů Projektu Euroaspire

Case reports

447

What may cause diabetes

Miroslav Pernický, Juraj Papinčák, Adriana Reptová, Soňa Kiňová, Ján Murín

Internal Medicine

2015 Issue 5